SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-21-009835
Filing Date
2021-05-11
Accepted
2021-05-11 16:53:55
Documents
1
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162076642191509.html 4  
1 FORM 4 wf-form4_162076642191509.xml 4 3064
  Complete submission text file 0001628280-21-009835.txt   4444
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERECOR INC. 400 EAST PRATT STREET, SUITE 606 BALTIMORE MD 21202
Business Address
Miller Joseph M (Reporting) CIK: 0001746372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 21912144